COM:2SEVENTYBIO
2seventy bio
- Stock
Last Close
3.16
22/11 21:00
Market Cap
197.91M
Beta: -
Volume Today
483.25K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 63.80M - | 6.74M 89.43% | -50.24M 845.18% | 6.82M 113.57% | |||
average payables | 13.77M - | 6.59M 52.16% | 6.62M 0.43% | 6.62M 0.03% | |||
average receivables | 9.06M - | 13.84M 52.82% | 18.98M 37.09% | 10.48M 44.78% | |||
book value per share | 1.88 - | 3.20 70.81% | 15.31 377.81% | 8.71 43.10% | 5.18 40.53% | ||
capex per share | -2.18 - | -2.57 17.59% | -0.96 62.75% | -0.83 12.86% | -0.64 23.05% | -0.28 56.10% | |
capex to depreciation | -3.81 - | -4.75 24.67% | -1.69 64.45% | -1.20 29.07% | -1.98 65.43% | -1.35 31.94% | |
capex to operating cash flow | 0.35 - | 0.29 17.33% | 0.33 14.26% | 0.09 71.21% | 0.10 1.88% | 0.08 13.74% | |
capex to revenue | -0.93 - | -1.35 44.88% | -0.09 93.35% | -0.36 300.18% | -0.25 30.47% | -0.14 44.68% | |
cash per share | -5.74 - | -5.48 4.47% | 11.28 305.85% | 7.47 33.76% | 4.40 41.06% | ||
days of inventory on hand | 8.63K - | -3.31K 138.34% | 189.86 105.74% | ||||
days payables outstanding | 2.50K - | 483.78 80.64% | 174.67 63.89% | 100.34 42.55% | 1.05K 944.63% | ||
days sales outstanding | 61.19 - | 15.73 74.30% | 113.77 623.43% | 83.61 26.51% | |||
debt to assets | 0.42 - | 0.41 3.76% | 0.37 8.99% | 0.41 10.75% | 0.45 10.33% | ||
debt to equity | 3.06 - | 1.71 44.07% | 0.78 54.13% | 0.87 10.95% | 1.01 15.53% | ||
dividend yield | |||||||
earnings yield | -0.62 - | -1.01 61.87% | -0.43 57.27% | -0.46 6.44% | -0.76 65.96% | -1.03 35.86% | |
enterprise value | 587.82M - | 575.87M 2.03% | 754.08M 30.95% | 533.06M 29.31% | 392.12M 26.44% | ||
enterprise value over ebitda | -1.82 - | -5.08 178.75% | -2.41 52.57% | -2.12 11.88% | -1.65 22.25% | ||
ev to operating cash flow | -2.83 - | -8.49 200.52% | -3.64 57.12% | -2.25 38.28% | -2.35 4.54% | ||
ev to sales | 13.27 - | 2.32 82.51% | 13.83 495.91% | 5.83 57.88% | 3.91 32.95% | ||
free cash flow per share | -8.46 - | -11.50 35.87% | -3.87 66.36% | -9.64 149.37% | -7.30 24.35% | -3.67 49.73% | |
free cash flow yield | -0.61 - | -0.83 35.87% | -0.28 66.36% | -0.38 33.98% | -0.78 106.93% | -0.86 10.32% | |
graham net net | -17.14 - | -12.62 26.42% | -7.62 39.58% | -1.61 78.87% | -1.89 17.37% | ||
graham number | 24.21 - | 20.68 14.57% | 63.64 207.67% | 37.39 41.25% | 22.69 39.32% | ||
income quality | 0.73 - | 0.65 11.38% | 0.56 12.99% | 0.71 25.53% | 0.93 31.69% | 0.77 17.80% | |
intangibles to total assets | 0 - | 0.07 Infinity% | 0.06 16.07% | 0.03 51.89% | 0.03 2.04% | 0.01 60.44% | |
interest coverage | -13.14 - | 30.88 - | |||||
interest debt per share | 5.74 - | 5.48 4.47% | 12.01 119.18% | 7.34 38.86% | 5.21 29.06% | ||
inventory turnover | 0.04 - | -0.11 360.85% | 1.92 1,842.83% | ||||
invested capital | 3.06 - | 1.71 44.07% | 0.78 54.13% | 0.87 10.95% | 1.01 15.53% | ||
market cap | 320.67M - | 320.67M 0% | 320.67M 0% | 602.28M 87.82% | 333.92M 44.56% | 210.41M 36.99% | |
net current asset value | -250.41M - | -212.89M 14.99% | -108.29M 49.13% | -45.32M 58.15% | -72.36M 59.68% | ||
net debt to ebitda | -0.83 - | -2.25 171.81% | -0.48 78.46% | -0.79 63.53% | -0.76 3.55% | ||
net income per share | -8.58 - | -13.88 61.87% | -5.93 57.27% | -11.75 98.11% | -7.13 39.33% | -4.42 38.09% | |
operating cash flow per share | -6.28 - | -8.93 42.23% | -2.91 67.40% | -8.81 202.64% | -6.65 24.47% | -3.39 49.11% | |
payables turnover | 0.15 - | 0.75 416.55% | 2.09 176.97% | 3.64 74.07% | 0.35 90.43% | ||
receivables turnover | 5.96 - | 23.21 289.08% | 3.21 86.18% | 4.37 36.07% | |||
research and ddevelopement to revenue | 3.67 - | 6.72 82.92% | 1.19 82.22% | 4.80 302.08% | 2.72 43.41% | 2.30 15.44% | |
return on tangible assets | -1.11 - | -0.47 57.48% | -0.37 20.37% | -0.40 6.51% | -0.39 2.37% | ||
revenue per share | 2.34 - | 1.90 18.84% | 10.65 460.15% | 2.32 78.22% | 2.57 10.66% | 2.04 20.65% | |
roe | -7.40 - | -1.85 74.98% | -0.77 58.54% | -0.82 6.64% | -0.85 4.11% | ||
roic | -1.10 - | -0.50 54.00% | -0.32 36.44% | -0.31 3.63% | -0.31 0.04% | ||
sales general and administrative to revenue | |||||||
shareholders equity per share | 1.88 - | 3.20 70.81% | 15.31 377.81% | 8.71 43.10% | 5.18 40.53% | ||
stock based compensation to revenue | 0.75 - | 1.40 87.38% | 0.25 82.45% | 1.00 307.58% | 0.45 55.23% | 0.32 28.58% | |
tangible asset value | 21.16M - | 55.86M 164.00% | 337.87M 504.89% | 291.11M 13.84% | 248.71M 14.57% | ||
tangible book value per share | 0.91 - | 2.40 164.00% | 14.38 499.45% | 8.17 43.19% | 5.05 38.21% | ||
working capital | -82.56M - | -50.76M 38.51% | 193.18M 480.54% | 221.09M 14.45% | 177.99M 19.50% |
All numbers in USD (except ratios and percentages)